Theratechnologies Inc (TH) COM NPV
Sell:3.51 CADBuy:3.78 CAD
0.06 CAD
(1.69%)
- This stock can be held in a
Stocks and Shares ISA0.06 CAD
(1.69%)0.06 CAD
(1.69%)Company Information
About this company
Theratechnologies Inc. is a Canada-based specialty biopharmaceutical company focused on the commercialization of innovative therapies. The Company offers prescription products for individuals with human immunodeficient virus (HIV) in the United States and its pipeline is focused on specialized therapies designed to address unmet medical needs in both HIV and oncology. It markets two HIV products, namely EGRIFTA SV and Trogarzo; and has research programs in HIV and oncology. EGRIFTA SV is the therapy for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. Trogarzo injection is used with other antiretrovirals to treat HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 who are failing their current regimen. Its pipeline includes Donidalorsen and Olezarsen, and the SORT1+ oncology platform. The Company is also focusing on tesamorelin life-cycle management in lipodystrophy.
Key people
Key facts
- EPICTH
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINCA88338H7040
- Market capCA$165.99m
- Employees94
- Shares in issue45.98m
- ExchangeToronto Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.